Skip navigation

Achieve Contracting Excellence and Compliance with the “Big Four” Federal Pricing Programs

November 7-8, 2018
  • Baltimore, MD
Critical, Breaking News Impacting Manufacturers in the Government and Drug Pricing Industry: HHS Set to Implement Long Delayed 340B Final Rule in January
CMS Finalizes Site Neutral Payment Rule

Now in its tenth year, CBI’s Federal Pricing and Reporting conference elevates the conversation and dives deep into the complexity of contracting with the “Big Four” federal programs. This must-attend, highly acclaimed meeting offers bio/pharma manufacturers best practices and timely updates from government officials and industry counterparts on pricing models and processes for complying with complicated rules and regulations. Join the hundreds who have benefited over the years and gain invaluable learnings to stay profitable in this low-margin, highly complex market.

highlighted speakers graphic


  • Hear from expert leaders within the VA, DoD and PHS
  • Ensure compliance and avoid pre-award and post-award issues
  • Effectively manage TRICARE dispute claims and mitigate
    unprocessed disputes
  • Receive answers to critical questions related to TAA Non-Compliant Covered Drugs Policy and its specific role in the Acetris Health LLC v. United States court cases
  • Navigate the recent and impending changes to 340B legislation and guidance
  • Discuss the financial implications of government contracting strategies in the context of GTN
  • Analyze and build your understanding of non-FAMP and FCP and the calculations and data involved
  • Hear directly from the VA OIG regarding FSS contract compliance and audit expectations

Previous Attendee Acclaim:

Love the size of the sessions, it lends to knowledge sharing and
a lot of great insightful questions and answers.

Director, Government Pricing and Compliance, Amneal Pharmaceuticals

Very informative, I’m new to this channel and learned a lot.
Thank you!

Associate Director, Policy and Reimbursement Lead, UCB, Inc.

Especially valuable to have VA personnel present and available for discussion. Lots of expertise by speakers and the audience.

Federal Accounts Director, Arbor Pharmaceuticals

The conference gave me valuable information and industry contacts that will be useful in our relations and dealings with the government.

Senior Manager, National Accounts, Sagent Pharmaceuticals

Timely and relevant information sharing from industry experts that has practical application I can take back to the office with me.

Senior Government Pricing Analyst, AstraZeneca

As someone who works with VA, DOD and PHS, this program has consistently given me an update and preparation for the coming year!

Federal Accounts, Teva Pharmaceuticals

It is beneficial to attend to hear the important factors of
government pricing reporting.

Manager, Government Pricing, Merck

Need to keep having this meeting!

Senior Director, Pricing and Contracting, Santarus Inc.

Having VA, NAC and OIG speakers at this conference is
very helpful and informative. Great choices.

Sr. Analyst Government Pricing, Daiichi Sankyo